Literature summary for 1.14.14.32 extracted from

Vasaitis, T.; Belosay, A.; Schayowitz, A.; Khandelwal, A.; Chopra, P.; Gediya, L.K.; Guo, Z.; Fang, H.B.; Njar, V.C.; Brodie, A.M.
Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer (2008), Mol. Cancer Ther., 7, 2348-2357.

Search for more literature for 1.14.14.32

Application

Application	Comment	Organism
medicine	inhibitors of 17alpha-hydroxylase/17,20 lyase are a class of anti-prostate cancer agents	Homo sapiens

Inhibitors

Inhibitors	Comment	Organism	Structure
17-(1H-1,2,3-triazol-1-yl)androsta-4,16-dien-3-one	VN/85-1	Homo sapiens
17-(1H-imidazole-1-yl)androsta-4,16-dien-3-one	VN/108-1	Homo sapiens
3beta-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene	VN/87-1	Homo sapiens
3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene	VN/124-1	Homo sapiens
abiraterone	-	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
LAPC4 cell	-	Homo sapiens	-

Synonyms

Synonyms	Comment	Organism
17alpha-hydroxylase/17,20-lyase	-	Homo sapiens
CYP17	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)